Current Edition


AbbVie’s blockbuster weighed down by safety concerns for a similar Pfizer drug

For years, AbbVie’s business has relied on Humira. One of the world’s top-selling medicines, Humira brought in close to $20 billion for AbbVie in each …

Continue Reading →

Suven Life Sciences gets patents in China and US

These patents add to the similar protections won in countries such as India, Korea, Singapore, Canada, Japan and Australia in the past. Suven Life Sciences …

Continue Reading →